First human trial of COVID-19 vaccine finds it is safe and induces rapid immune response
A study of 108 adults finds that the vaccine produced neutralizing antibodies and T-cell response against SARS-CoV-2, but further research is needed to confirm whether the vaccine protects against SARS-COV-2 infection.
Read Original Article: First human trial of COVID-19 vaccine finds it is safe and induces rapid immune response »
